![Duane A. Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Duane A. Morris
Geschäftsführer bei
C3J Therapeutics, Inc.
Profil
Duane A. Morris is currently the Vice President-Operations at C3J Therapeutics, Inc. He previously held positions as the Director-Pharmaceutical Manufacturing at Syntex Corp, Manufacturing Director at Syntex Laboratories, Inc., Vice President-Operations at ID Biomedical Corp., Vice President-Operations at Cypress Bioscience, Inc., Chief Operating Officer at Response Biomedical Corp., Vice President-Production & Facilities at C3 Jian LLC, General Manager at GlaxoSmithKline Biologicals NV, and General Manager & Vice President at GSK Products, Inc. Mr. Morris obtained his undergraduate degree from the College of Saint Mary.
Aktive Positionen von Duane A. Morris
| Unternehmen | Position | Beginn |
|---|---|---|
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Geschäftsführer | 01.01.2012 |
Ehemalige bekannte Positionen von Duane A. Morris
| Unternehmen | Position | Ende |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Geschäftsführer | 01.05.2023 |
| RESPONSE BIOMEDICAL CORP | Geschäftsführer | 29.10.2010 |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 25.02.2009 |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Corporate Officer/Principal | 01.12.2006 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Geschäftsführer | 01.01.2005 |
Ausbildung von Duane A. Morris
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Response Biomedical Corp.
 Response Biomedical Corp. Medical SpecialtiesHealth Technology Develops acute care diagnostic testing products | Health Technology |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections | Health Technology |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
GSK Products, Inc.
 GSK Products, Inc. Wholesale DistributorsDistribution Services Beauty & barber supply concern | Distribution Services |
College of Saint Mary
 College of Saint Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntex Laboratories, Inc. | |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
